EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Treatment Outcomes of Multiple Myeloma in Developing Countries: A Systematic Review and Meta-Analysis

Jehad Almasri iD, Bashar Hasan iD, Zin Tarakji, Faris W Naffa' iD, Lynn Warner iD, Hira Mian, Rajshekhar Chakraborty, Ghulam Rehman Mohyuddin iD, Zaid Abdel-Rahman, Samer Al Hadidi iD

Clinical Hematology International · 08.10.2025 · 7 (4)

DOI: 10.46989/001c.144582 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical Hematology International, online erschienen am 08.10.2025. Verfasst von Jehad Almasri und 9 weiteren Autor:innen. Beteiligte Einrichtung: University of Cincinnati Cancer Center, Cincinnati, OH, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma (MM) treatment outcomes in developing countries may be impacted by resource constraints. This systematic review and meta-analysis evaluated efficacy outcomes of MM treatments across developing regions. Comprehensive searches in five major databases identified 37 eligible studies from Asia, Africa, Latin America, and Eastern Europe. The Newcastle-Ottawa Scale was used to assess risk of bias. Newer novel agents including daratumumab, carfilzomib, and pomalidomide showed limited use across studies. For patients receiving autologous stem cell transplantation (ASCT), the pooled overall survival rate at longest follow-up (2.5-12.5 years) was 62% (95% CI: 48-75%), with high heterogeneity (I²=92%), while the progression-free survival rate at longest follow-up (3-8 years) was 44% (95% CI: 23-67%). Comparative analyses demonstrated ASCT was associated with significantly superior 5-year survival compared to conventional chemotherapy (RR: 1.59; 95% CI: 1.38-1.82). Bortezomib-based regimens showed better outcomes than thalidomide-based therapies (HR for overall survival (OS) at 4 years: 0.73; 95% CI: 0.53-1.0) and alkylating agent-based regimens (HR: 0.48; 95% CI: 0.28-0.83). Despite resource limitations, ASCT and certain novel agents are associated with improved survival outcomes for MM patients in developing countries. However, substantial heterogeneity in outcomes suggests variability in healthcare infrastructure, treatment accessibility, and clinical expertise across these regions.

Schlagwörter

Stichwörter der Autor:innen

Hematopoietic Stem Cell Transplantation.Multiple myelomadeveloping countriesglobal

Autor:innen und Institutionen

  • University of Cincinnati Cancer Center, Cincinnati, OH, USA.
  • Evidence-Based Practice Center, Mayo Clinic, Rochester, MN, USA.
  • Mayo Clinic, Rochester, MN, USA.
  • Internal Medicine Department, Ascension Saint Agnes, Baltimore, MD, USA.
  • Health Science Library, University of Cincinnati, Cincinnati, OH, USA.
  • McMaster University, Hamilton, Ontario, Canada.

ORCID-Profile: Jehad Almasri, Bashar Hasan, Faris W Naffa', Lynn Warner, Ghulam Rehman Mohyuddin, Samer Al Hadidi

Zitieren

APA

Almasri, J., Hasan, B., Tarakji, Z., Naffa', F. W., Warner, L., Mian, H., Chakraborty, R., Mohyuddin, G. R., Abdel-Rahman, Z., & Al Hadidi, S. (2025). Treatment Outcomes of Multiple Myeloma in Developing Countries: A Systematic Review and Meta-Analysis. Clinical Hematology International, 7(4). https://doi.org/10.46989/001c.144582

Vancouver

Almasri J, Hasan B, Tarakji Z, Naffa' FW, Warner L, Mian H, et al. Treatment Outcomes of Multiple Myeloma in Developing Countries: A Systematic Review and Meta-Analysis. Clinical Hematology International. 2025;7(4). doi:10.46989/001c.144582

BibTeX
@article{Almasri2025,
  author = {Almasri, Jehad and Hasan, Bashar and Tarakji, Zin and Naffa', Faris W and Warner, Lynn and Mian, Hira and Chakraborty, Rajshekhar and Mohyuddin, Ghulam Rehman and Abdel-Rahman, Zaid and Al Hadidi, Samer},
  title = {Treatment Outcomes of Multiple Myeloma in Developing Countries: A Systematic Review and Meta-Analysis},
  journal = {Clinical Hematology International},
  year = {2025},
  volume = {7},
  number = {4},
  doi = {10.46989/001c.144582}
}
Kostenlos starten →